References
- WHO. Cancer. 2020 [ cited 2022 Mar 22]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
- Viswanath K, Breen N, Meissner H. Cancer knowledge and disparities in the information age. J Health Commun. 2006;11(S1):1–17.
- Organization, W.H. World Health Organization-WHO. 2000.
- Chen J, Jiang Z, Zhang YS. Smart transformable nanoparticles for enhanced tumor theranostics. Appl Phys Rev. 2021;8(4):041321.
- Rojo J, Morales JC, Penadés S. Carbohydrate-carbohydrate interactions in biological and model systems. Springer, Berlin, Heidelberg. Germany. Host-Guest Chemistry; 2002. p. 45–92.
- Delbianco M, Bharate P, Varela-Aramburu S. Carbohydrates in supramolecular chemistry. Chem Rev. 2016;116(4):1693–1752.
- Blanco JLJ, Mellet CO, Fernández JMG. Multivalency in heterogeneous glycoenvironments: hetero-glycoclusters,-glycopolymers and-glycoassemblies. chem. Soc. Rev. 2013;42(11):4518–4531.
- Chabre YM, Roy R. Multivalent glycoconjugate syntheses and applications using aromatic scaffolds. Chem Soc Rev. 2013;42(11):4657–4708.
- Marradi M, Chiodo F, García I. Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem Soc Rev. 2013;42(11):4728–4745.
- Gabius H-J, Kayser K. Introduction to glycopathology: the concept, the tools and the perspectives. Diagnostic Pathology. 2014;9:4.
- Danguy A, Camby I, Kiss R. Biochimica et Biophysica Acta (BBA) - general subjects. Galectins and cancer. 2002;1572(2):285–293.
- Chi A, Zhang Y, Kang Y. Metabolic mechanism of a polysaccharide from Schisandra chinensis to relieve chronic fatigue syndrome. Int J Biol Macromol. 2016;93:322–332.
- Li Q, Guo G, Meng F. A naturally derived, growth factor-binding polysaccharide for therapeutic angiogenesis. ACS Macro Lett. 2016;5(5):617–621.
- Chang R. Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants. J Altern Complementary Med. 2002;8(5):559–565.
- Singh D, Han SS, Shin EJ. Polysaccharides as nanocarriers for therapeutic applications. J Biomed Nanotechnol. 2014;10(9):2149–2172.
- Wen Y, Oh JK. Recent strategies to develop polysaccharide‐based nanomaterials for biomedical applications. Macromol Rapid Commun. 2014;35(21):1819–1832.
- Vasiliu S, et al. Microbial exopolysaccharides for biomedical applications. Frontiers in Biomaterials: unfolding the Biopolymer Landscape/eds. V. Pillay, YE Choonara, P. Kumar. Sharjah: Bentham Sci Publ UAE. 2016;2:180–238.
- Crowe JH, Crowe LM, Chapman D. Preservation of membranes in anhydrobiotic organisms: the role of trehalose. Science. 1984;223(4637):701–703.
- Kwong PD, Wyatt R, Robinson J. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 1998;393(6686):648–659.
- Xie YL, Wang MJ, Yao SJ. Preparation and characterization of biocompatible microcapsules of sodium cellulose sulfate/chitosan by means of layer-by-layer self-assembly. Langmuir. 2009;25(16):8999–9005.
- Zhao L, Fan F, Wang P. Culture medium optimization of a new bacterial extracellular polysaccharide with excellent moisture retention activity. Appl Microbiol Biotechnol. 2013;97(7):2841–2850.
- El-Boubbou K, Zhu DC, Vasileiou C. Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging. J Am Chem Soc. 2010;132(12):4490–4499.
- Knop K, Hoogenboom R, Fischer D. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl. 2010;49(36):6288–6308.
- Besheer A, Vogel J, Glanz D. Characterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronics. Mol Pharm. 2009;6(2):407–415.
- Lemarchand C, Gref R, Couvreur P. Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm. 2004;58(2):327–341.
- Noga M, Edinger D, Rödl W. Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase. J Control Release. 2012;159(1):92–103.
- Ferguson EL, Duncan R. Dextrin-phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate. Biomacromolecules. 2009;10(6):1358–1364.
- Duncan R, Gilbert HRP, Carbajo RJ. Polymer masked-unmasked protein therapy. 1. Bioresponsive dextrin-trypsin and -melanocyte stimulating hormone conjugates designed for alpha-amylase activation. Biomacromolecules. 2008;9(4):1146–1154.
- Osterberg E, Bergström K, Holmberg K. Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG. J Biomed Mater Res. 1995;29(6):741–747.
- Noga M, Edinger D, Kläger R. The effect of molar mass and degree of hydroxyethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes. Biomaterials. 2013;34(10):2530–2538.
- Saha RN, Vasanthakumar S, Bende G. Nanoparticulate drug delivery systems for cancer chemotherapy. Mol Membr Biol. 2010;27(7): 215–231.
- Peer D, Karp JM, Hong S. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751.
- Su J, Chen F, Cryns VL. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells. J Am Chem Soc. 2011;133(31): 11850–11853.
- Kumar S, Singh S, Senapati S. Controlled drug release through regulated biodegradation of poly (lactic acid) using inorganic salts. Int J Biol Macromol. 2017;104:487–497.
- Mo R, Jiang T, Gu Z. Recent progress in multidrug delivery to cancer cells by liposomes. Nanomedicine. 2014;9(8):1117–1120.
- Dong Y, Eltoukhy AA, Alabi CA. Lipid‐like nanomaterials for simultaneous gene expression and silencing in vivo. Adv Healthc Mater. 2014;3(9):1392–1397.
- Gu FX, Karnik R, Wang AZ. Targeted nanoparticles for cancer therapy. Nano Today. 2007;2(3): 14–21.
- Shih H, Lin -C-C. Photoclick hydrogels prepared from functionalized cyclodextrin and poly (ethylene glycol) for drug delivery and in situ cell encapsulation. Biomacromolecules. 2015;16(7):1915–1923.
- Sun W, Gu Z. Engineering DNA scaffolds for delivery of anticancer therapeutics. Biomater Sci. 2015;3(7):1018–1024.
- Cho K, Wang X, Nie S. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14(5):1310–1316. https://doi.org/https://doi.org/10.1158/1078-0432.CCR-07-1441.
- Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther. 2000;85(3):217–229.
- Wei L, Chen J, Ding J. Sequentially stimuli-responsive anticancer nanomedicines. Future Med. 2021;16(4):261–264.
- Raza A, Rasheed T, Nabeel F. Endogenous and exogenous stimuli-responsive drug delivery systems for programmed site-specific release. Molecules. 2019;24(6):1117. https://doi.org/https://doi.org/10.3390/molecules24061117.
- Such GK, Yan Y, Johnston APR. Interfacing materials science and biology for drug carrier design. Adv Mater. 2015;27(14):2278–2297. https://doi.org/https://doi.org/10.1002/adma.201405084.
- Deirram N, Zhang C, Kermaniyan SS. pH‐responsive polymer nanoparticles for drug delivery. Macromol Rapid Commun. 2019;40(10):1800917. https://doi.org/https://doi.org/10.1002/marc.201800917.
- Fan X, Yang L, Wang T. pH-responsive cellulose-based dual drug-loaded hydrogel for wound dressing. Eur Polym J. 2019;121:109290.
- Yilmaz G, Guler E, Geyik C. pH responsive glycopolymer nanoparticles for targeted delivery of anti-cancer drugs. Molecular Sys Design & Eng. 2018;3(1):150–158. https://doi.org/https://doi.org/10.1039/C7ME00086C.
- Tian B, Hua S, Liu J Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: areview . Carbohydrate pol. 2020;232:115805.
- Beňová E, Bergé-Lefranc D, Zeleňák V. Adsorption properties, the pH-sensitive release of 5-fluorouracil and cytotoxicity studies of mesoporous silica drug delivery matrix. Appl Surf Sci. 2020;504:144028.
- Shen Y, Li M, Liu T. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells. Int J Nanomedicine. 2019;14:4029.
- Shen Q, Shen Y, Jin F. Paclitaxel/hydroxypropyl-β-cyclodextrin complex-loaded liposomes for overcoming multidrug resistance in cancer chemotherapy. J Liposome Res. 2020;30(1):12–20. https://doi.org/https://doi.org/10.1080/08982104.2019.1579838.
- Bai Y, Liu C-P, Xie F-Y, et al. Construction of β-cyclodextrin-based supramolecular hyperbranched polymers self-assemblies using AB2-type macromonomer and their application in the drug delivery field. Vol. 213. Carbohydrate polymers; 2019. p. 411–418.
- Wang J, Li D, Fan Y. Core–shell tecto dendrimers formed via host–guest supramolecular assembly as pH-responsive intelligent carriers for enhanced anticancer drug delivery. Nanoscale. 2019;11(46):22343–22350. https://doi.org/https://doi.org/10.1039/C9NR08309J.
- Zhang Y, Cai L, Li D. Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas. Nano Res. 2018;11(9):4806–4822. https://doi.org/https://doi.org/10.1007/s12274-018-2066-0.
- Liu P, Zhang R. Polymer microspheres with high drug-loading capacity via dual-modal drug-loading for modulating controlled release property in pH/reduction dual-responsive tumor-specific intracellular triggered doxorubicin release. Colloids and Surfaces A. Phys Eng Aspect. 2019;577:291–295. https://doi.org/https://doi.org/10.1016/j.colsurfa.2019.05.089.
- Ma W, Chen Q, Xu W. Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer. Nano Res. 2021;14(3): 846–857. https://doi.org/https://doi.org/10.1007/s12274-020-3124-y.
- Wang M, Wang T, Wang D. Acid and light stimuli-responsive mesoporous silica nanoparticles for controlled release. J Mater Sci. 2019;54(8):6199–6211. https://doi.org/https://doi.org/10.1007/s10853-019-03325-x.
- Yu HS, Lee ES. Honeycomb-like pH-responsive γ-cyclodextrin electrospun particles for highly efficient tumor therapy. Vol. 230. Carbohydrate polymers; 2020. p. 115563.
- He H, Chen S, Zhou J. Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel. Biomaterials. 2013;34(21):5344–5358. https://doi.org/https://doi.org/10.1016/j.biomaterials.2013.03.068.
- Mondal B, Pandey B, Parekh N. Amphiphilic mannose-6-phosphate glycopolypeptide-based bioactive and responsive self-assembled nanostructures for controlled and targeted lysosomal cargo delivery. Biomater Sci. 2020;8(22):6322–6336. https://doi.org/https://doi.org/10.1039/D0BM01469A.
- Mal NK, Fujiwara M, Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature. 2003;421(6921):350–353.
- Zhu Y, Fujiwara M. Installing dynamic molecular photomechanics in mesopores: a multifunctional controlled‐release nanosystem. Angew Chem. 2007;46(13):2241–2244.
- Hong S, Li Z, Li C. β-Cyclodextrin grafted polypyrrole magnetic nanocomposites toward the targeted delivery and controlled release of doxorubicin. Appl Surf Sci. 2018;427:1189–1198.
- Brevet D, Gary-Bobo M, Raehm L. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Comm. 2009;(12):1475–1477. https://doi.org/https://doi.org/10.1039/b900427k.
- Wang P, Huang C, Xing Y. NIR-light-and pH-responsive graphene oxide hybrid cyclodextrin-based supramolecular hydrogels. Langmuir. 2019;35(4):1021–1031. https://doi.org/https://doi.org/10.1021/acs.langmuir.8b03689.
- Sun F, Zhang, P, Liu, Y, et al. A photo-controlled hyaluronan-based drug delivery nanosystem for cancer therapy. Vol. 206. Carbohydrate polymers; 2019. p. 309–318.
- Srinivasan S, Manchanda R, Fernandez-Fernandez A. Near-infrared fluorescing IR820-chitosan conjugate for multifunctional cancer theranostic applications. J Photochem Photobiol B Biol. 2013;119:52–59.
- Davidson-Rozenfeld G, Stricker L, Simke J. Light-responsive arylazopyrazole-based hydrogels: their applications as shape-memory materials, self-healing matrices and controlled drug release systems. Polym Chem. 2019;10(30):4106–4115. https://doi.org/https://doi.org/10.1039/C9PY00559E.
- Kim J-H, Lu T-M. Bio-inspired Janus composite nanoscrolls for on-demand tumour targeting. RSC Adv. 2016;6(21):17179–17187.
- Zhao Y, Vivero-Escoto JL, Slowing II. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery. Expert Opin Drug Deliv. 2010;7(9):1013–1029.
- Yi P, Wang Y, Zhang S, et al. Stimulative nanogels with enhanced thermosensitivity for therapeutic delivery via β-cyclodextrin-induced formation of inclusion complexes. Vol. 166. Carbohydrate polymers; 2017. p. 219–227.
- Shafiee S, Ahangar HA, Saffar A. Taguchi method optimization for synthesis of Fe3O4@ chitosan/Tragacanth Gum nanocomposite as a drug delivery system. Carbohydr Polym. 2019;222:114982.
- Pourjavadi A, Tehrani ZM. Poly (N-isopropylacrylamide)-coated β-cyclodextrin–capped magnetic mesoporous silica nanoparticles exhibiting thermal and pH dual response for triggered anticancer drug delivery. Int J Polym Mater Polym Biomater. 2017;66(7):336–348.
- Pan Q, Lv Y, Williams GR. Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems. Carbohydr Polym. 2016;151:812–820.
- Hussien NA, Işıklan N, Türk M. Pectin-conjugated magnetic graphene oxide nanohybrid as a novel drug carrier for paclitaxel delivery. Artif Cells Nanomed Biotechnol. 2018;46(sup1):264–273.
- Jaison D, Chandrasekaran G, Mothilal M. pH-sensitive natural almond gum hydrocolloid based magnetic nanocomposites for theragnostic applications. Int J Biol Macromol. 2020;154:256–266.
- Gerola AP, Silva DC, Jesus S. Synthesis and controlled curcumin supramolecular complex release from pH-sensitive modified gum-Arabic-based hydrogels. RSC Adv. 2015;5(115):94519–94533. https://doi.org/https://doi.org/10.1039/C5RA14331D.
- Sayadnia S, Arkan E, Jahanban‐Esfahlan R. Tragacanth gum-based pH -responsive magnetic hydrogels for “smart” chemo/hyperthermia therapy of solid tumors. ?Polym Adv Technol. 2021;32(1):262–271. https://doi.org/https://doi.org/10.1002/pat.5082.
- Jeon H, Kim J, Lee YM. Poly-paclitaxel/cyclodextrin-SPION nano-assembly for magnetically guided drug delivery system. J Control Release. 2016;231:68–76.
- Zhang L, Yu F, Cole AJ. Gum Arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging. AAPS J. 2009;11(4):693–699. https://doi.org/https://doi.org/10.1208/s12248-009-9151-y.
- Wu X, Sun X, Guo Z. In vivo and in situ tracking cancer chemotherapy by highly photostable nir fluorescent theranostic prodrug. J Am Chem Soc. 2014;136(9):3579–3588. https://doi.org/https://doi.org/10.1021/ja412380j.
- Lee MH, Yang Z, Lim CW. Disulfide-cleavage-triggered chemosensors and their biological applications. Chem Rev. 2013;113(7):5071–5109. https://doi.org/https://doi.org/10.1021/cr300358b.
- Yang Z, Lee JH, Jeon HM. Folate-based near-infrared fluorescent theranostic gemcitabine delivery. J Am Chem Soc. 2013;135(31):11657–11662. https://doi.org/https://doi.org/10.1021/ja405372k.
- Chen H, Tham HP, Ang CY. Responsive prodrug self-assembled vesicles for targeted chemotherapy in combination with intracellular imaging. ACS Appl Mater Interfaces. 2016;8(37):24319–24324. https://doi.org/https://doi.org/10.1021/acsami.6b08044.
- Pandey B, Patil NG, Bhosle GS. Amphiphilic glycopolypeptide star copolymer-based cross-linked nanocarriers for targeted and dual-stimuli-responsive drug delivery. Bioconjug Chem. 2018;30(3):633–646. https://doi.org/https://doi.org/10.1021/acs.bioconjchem.8b00831.
- Zhou Y, Wen H, Gu L. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells. J Nanobiotechnology. 2017;15(1):1–17. https://doi.org/https://doi.org/10.1186/s12951-017-0316-z.
- Sang MM, Liu FL, Wang Y. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer. Drug Deliv. 2018;25(1): 1846–1857. https://doi.org/https://doi.org/10.1080/10717544.2018.1486472.
- Feng X, Xu W, Liu J. Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy. Sci Bull. 2021;66(4):362–373. https://doi.org/https://doi.org/10.1016/j.scib.2020.07.013.
- Eskandari P, Bigdeli B, Porgham Daryasari M. Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery. J Drug Target. 2019;27(10):1084–1093. https://doi.org/https://doi.org/10.1080/1061186X.2019.1599379.
- Guan X, Chen Y, Wu X. Enzyme-responsive sulfatocyclodextrin/prodrug supramolecular assembly for controlled release of anti-cancer drug chlorambucil. Chem Comm. 2019;55(7):953–956. https://doi.org/https://doi.org/10.1039/C8CC09047E.
- Rastegari B, Karbalaei-Heidari HR, Zeinali S. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: synthesis, characterization and cytotoxicity studies. Colloids Surf B Biointerfaces. 2017;158:589–601.
- Bernardos A, Mondragón L, Aznar E. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with saccharides. ACS nano. 2010;4(11):6353–6368. https://doi.org/https://doi.org/10.1021/nn101499d.
- Elias EJ, Anil S, Ahmad S. Colon targeted curcumin delivery using guar gum. Nat Prod Commun. 2010;5(6):1934578X1000500621. https://doi.org/https://doi.org/10.1177/1934578X1000500621.
- Mondal B, Dutta T, Gupta SS. Dual enzyme responsive mannose-6-phosphate based vesicle for controlled lysosomal delivery. Chem Comm. 2021;57(1):109–112.
- Fan Z, Wang Y, Xiang S. Dual-self-recognizing, stimulus-responsive and carrier-free methotrexate–mannose conjugate nanoparticles with highly synergistic chemotherapeutic effects. J Mat Chem B. 2020;8(9):1922–1934. https://doi.org/https://doi.org/10.1039/D0TB00049C.
- Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991–1003.
- Schroeder A, Honen R, Turjeman K. Ultrasound triggered release of cisplatin from liposomes in murine tumors. J Control Release. 2009;137(1):63–68. https://doi.org/https://doi.org/10.1016/j.jconrel.2009.03.007.
- Kheirolomoom A, Mahakian LM, Lai C-Y. Copper− doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. Mol Pharm. 2010;7(6):1948–1958. https://doi.org/https://doi.org/10.1021/mp100245u.
- Meng D, Guo L, Shi D. Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery. Nanomedicine. 2019;14(19): 2549–2565. https://doi.org/https://doi.org/10.2217/nnm-2019-0217.
- Yang SJ, Chang SM, Tsai KC, et al. Effect of chitosan‐alginate nanoparticles and ultrasound on the efficiency of gene transfection of human cancer cells. 2010;12(2):168–179. J Gene Med: A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications.
- Garg NK, Singh B, Jain A. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. Colloids Surf B Biointerfaces. 2016;146:114–126.
- Zhao Y, Butler EB, Tan M. Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis. 2013;4(3):e532.
- Liu X, Liu B, Gao S. Glyco-decorated tobacco mosaic virus as a vector for cisplatin delivery. J Mater Chem B. 2017;5(11):2078–2085. https://doi.org/https://doi.org/10.1039/C7TB00100B.
- Sun J, Sheng R, Luo T. Synthesis of diblock/statistical cationic glycopolymers with pendant galactose and lysine moieties: gene delivery application and intracellular behaviors. J Mater Chem B. 2016;4(27):4696–4706. https://doi.org/https://doi.org/10.1039/C6TB00969G.
- Hu Y, Xu B, Ji Q. A mannosylated cell-penetrating peptide-graft-polyethylenimine as a gene delivery vector. Biomaterials. 2014;35(13):4236–4246. https://doi.org/https://doi.org/10.1016/j.biomaterials.2014.01.065.
- Kannagi R, Sakuma K, Miyazaki K. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers. Cancer Sci. 2010;101(3):586–593. https://doi.org/https://doi.org/10.1111/j.1349-7006.2009.01455.x.
- Mereiter S, Balmaña M, Campos D. Glycosylation in the era of cancer-targeted therapy: where are we heading? Cancer Cell. 2019;36(1):6–16. https://doi.org/https://doi.org/10.1016/j.ccell.2019.06.006.
- Scott E, Elliott DJ, Munkley J. Tumour associated glycans: a route to boost immunotherapy? Clin Chim Acta. 2020;502:167–173.
- Yan H, Kamiya T, Suabjakyong P, et al. Targeting C-Type Lectin Receptors for Cancer Immunity. Vol. 6. Front Immunol; 2015. p. 408.
- Beckwith DM, Cudic M. Tumor-associated O-glycans of MUC1: carriers of the glyco-code and targets for cancer vaccine design. Vol. 47. Semin Immunol; 2020. p. 101389.
- Cazet A, Julien S, Bobowski M. Consequences of the expression of sialylated antigens in breast cancer. Carbohydr Res. 2010;345(10):1377–1383. https://doi.org/https://doi.org/10.1016/j.carres.2010.01.024.
- Duinkerken S, Horrevorts SK, Kalay H. Glyco-dendrimers as intradermal anti-tumor vaccine targeting multiple Skin DC subsets. Theranostics. 2019;9(20):5797–5809. https://doi.org/https://doi.org/10.7150/thno.35059.
- Tekade RK, Sun X. The Warburg effect and glucose-derived cancer theranostics. Drug Discov Today. 2017;22(11):1637–1653.
- Sadeghzadeh M, Charkhlooiea G, Johari Daha F. Synthesis, radiolabeling and biological evaluation of (99m)Tc-labeled deoxyglucose derivatives for molecular imaging. Iran J Pharm Res. 2013;12(3):273–280.
- Lee SY, Kang MS, Jeong WY. Hyaluronic acid-based theranostic nanomedicines for targeted cancer therapy. Cancers (Basel). 2020;12(4):940. https://doi.org/https://doi.org/10.3390/cancers12040940.
- Awad NS, Paul V, AlSawaftah NM. Ultrasound-responsive nanocarriers in cancer treatment: a review. ACS Pharmacol Transl Sci. 2021;4(2):589–612. https://doi.org/https://doi.org/10.1021/acsptsci.0c00212.